CVC to drop $3.30bn Irca deal, risking Advent arbitration – report
CVC informed Advent several weeks ago of its intention to exit the signed acquisition agreement after carrying out a forensic review of Irca’s finances.
CVC informed Advent several weeks ago of its intention to exit the signed acquisition agreement after carrying out a forensic review of Irca’s finances.
Research strength, clinical capabilities, favourable regulatory policies and direct access to the Greater Bay Area are expanding Hong Kong’s value to medical-device companies, with HKSTP’s first MEDICA pavilion providing fresh...
When assessing foreign investment into India on a state-by-state basis, Chandigarh and Telangana punch impressively above their weight.
From localisation to advanced therapies: Saudi Arabia’s emerging pharmaceutical and biotechnology hub
Kioxia, Sandisk plan more than $31bn investment in Japan
Entering the Agentverse: Powering the next decade of mobile growth
Mercedes-Benz to expand India’s role in software, AI and sourcing – report